COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges

Multiple vaccines have recently been developed, and almost all the countries are presently vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 vaccines in use are administered via intramuscular (IM) injection, eliciting protective humor and cellular immunity. COVID-19...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi, Abbas Al Mutair
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2022-11-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	covid-19 sars-cov-2 intranasal vaccine mucosal immunity
Accés en línia:	http://dx.doi.org/10.1080/21645515.2022.2045853
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!